SCHEMBL9192075

SCHEMBL9192075

Nn1cc(Cl)c(=O)[nH]c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.57
GRIA1 P42261 2/20 0.45
GRIA2 P42262 2/20 0.45
GRIA4 P48058 2/20 0.45
GRIK5 Q16478 1/20 0.45
CRBN Q96SW2 1/20 0.40
PYGM P11217 1/20 0.36
CYP1A2 P05177 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
THPO P40225 1/20 0.34
GRIA3 P42263 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL646139 0.74 TDP1 (0.59) TDP1CRBNALDH1A1LMNAHPGD
SCHEMBL4379053 0.73 DAO (0.43) GRIA1GRIA2GRIA4GRIK5CRBN
SCHEMBL20998597 0.73 GRIA1 (0.41) TDP1GRIA1GRIA2GRIA4GRIK5
SCHEMBL9192590 0.73 TDP1 (0.57) TDP1GRIA1GRIA2GRIA4GRIK5
SCHEMBL9190653 0.73 TDP1 (0.57) TDP1GRIA1GRIA2GRIA4GRIK5
SCHEMBL400005 0.73 TDP1 (1.00) TDP1GRIA1GRIA2GRIA4GRIK5
SCHEMBL12702585 0.70 GRIA1 (0.39) TDP1GRIA1GRIA2GRIA4GRIK5
SCHEMBL17041835 0.70 TDP1 (0.53) TDP1CRBNCYP1A2KMT2AMEN1
SCHEMBL11254252 0.68 GRIA1 (0.53) GRIA1GRIA2GRIA4GRIK5CYP1A2
SCHEMBL18870686 0.68 TDP1 (0.52) TDP1CRBNDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0425669-B1 1-AMINO-5-HALOGENOURACILS, PROCESS FOR THEIR PREPARATION, AND CENTRAL NERVOUS SYSTEM DEPRESSANTS CONTAINING SAME AS ACTIVE INGREDIENT YAMASA SHOYU KK (JP) 1995-01-25 EP disclosed
US-5334593-A Anxiolytic drugs YAMASA SHOYU KABUSHIKI KAISHA (JP) 1994-08-02 US disclosed
US-5252576-A 1-amino-5-halogenouracils, process for their preparation, and central nervous system depressants containing same as active ingredient YAMASA SHOYU KABUSHIKI KAISHA (JP) 1993-10-12 US disclosed
EP-0509098-A1 ATARACTIC Yamasa Shoyu Kabushiki Kaisha (JP) 1992-10-21 EP disclosed
EP-0425669-A1 1-AMINO-5-HALOGENOURACILS, PROCESS FOR THEIR PREPARATION, AND CENTRAL NERVOUS SYSTEM DEPRESSANTS CONTAINING SAME AS ACTIVE INGREDIENT Yamasa Shoyu Kabushiki Kaisha also trading as Yamasa Corporation (JP) 1991-05-08 EP disclosed